BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

BIOLASE Technology, Inc. (BIOL) Announces Opening of Corporate Technology and Training Center


7/24/2012 8:51:48 AM

IRVINE, CA--(Marketwire - July 24, 2012) - BIOLASE, Inc. (NASDAQ: BIOL), the world's leading dental laser manufacturer and distributor, today announced the opening of the technology and training center at its corporate headquarters in Irvine, CA. The state-of-the-art facility has a hands-on lab featuring the Company's patented Waterlase dental laser technology, proprietary EPIC line of diode lasers and fully functional 3D digital imaging, including NewTom Cone Beam 3D imaging and BIOLASE DaVinci Imaging™ products. The training center will provide introductory and specialized training sessions for dental professionals seeking proficiency and certification training utilizing best-in-class BIOLASE products. The facility will also be used to continuously train and clinically educate the Company's sales team.

Under the guidance of experienced clinicians, the training courses will follow the teaching method of "Tell, Show, Do and Teach Each Other," employing a combination of lecture and hands-on instruction with extracted teeth and proxy dental models. Factory tours will also be provided to allow dental professionals a look into the development and manufacturing of BIOLASE products.

BIOLASE Chairman and CEO Federico Pignatelli said, "Advanced surgical and imaging products like ours require proper training. Creating a central hub for that activity is the most efficient way to deliver the best-in-class education and allows clinicians to interact with and among one another -- creating a better learning environment. When presented with the full range of benefits our technologies deliver, the result is often a repeat customer and BIOLASE becomes a more essential part of that practice. BIOLASE, in turn, moves closer to becoming the top provider of technology solutions in dentistry. In addition to the clinical and practice benefits of taking courses in-house at BIOLASE, practitioners will gain exposure to management and to research and development activity where their interaction and input helps to continue the feedback loop so important in being a leader in innovation."

BIOLASE's laser systems and imaging instruments advance the practice of dentistry by providing early diagnosis, the identification of more indications and a minimally invasive treatment without the use of anesthesia in a very biologically friendly fashion.

Courses to be offered in the new training center include Waterlase and Diode Laser Certification Training, Refresher classes, and Master Specialty courses in Endodontics, Periodontics and Pediatric Dentistry. A full range of 3D Imaging courses are in development. For more information on training and events, visit www.learnlasers.com.

The EPIC 10™ is not yet available for sale in the U.S. as it is pending 510k clearance from the Food and Drug Administration.

About BIOLASE, Inc.
BIOLASE, Inc., the World's leading Dental Laser Company, is a medical technology company that develops, manufactures and markets dental lasers and also distributes and markets dental imaging equipment; products that are focused on technologies that advance the practice of dentistry and medicine. The Company's laser products incorporate approximately 285 patented and patent pending technologies designed to provide biologically clinically superior performance with less pain and faster recovery times. Its imaging products provide cutting-edge technology at competitive prices to deliver the best results for dentists and patients. BIOLASE's principal products are dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications, and a full line of dental imaging equipment. BIOLASE has sold more than 19,600 lasers among 16,000 customers. Other products under development address ophthalmology and other medical and consumer markets.

For updates and information on laser and Waterlase dentistry, find BIOLASE at http://www.biolase.com, Twitter at http://twitter.com/GoWaterlase, and YouTube at http://www.youtube.com/user/Rossca08.

This press release may contain forward-looking statements within the meaning of safe harbor provided by the Securities Reform Act of 1995 that are based on the current expectations and estimates by our management. These forward-looking statements can be identified through the use of words such as "anticipates," "expects," "intends," "plans," "believes," "seeks," "estimates," "may," "will," and variations of these words or similar expressions. Forward-looking statements are based on management's current, preliminary expectations and are subject to risks, uncertainties and other factors which may cause the Company's actual results to differ materially from the statements contained herein, and are described in the Company's reports it files with the Securities and Exchange Commission, including its annual and quarterly reports. No undue reliance should be placed on forward-looking statements. Such information is subject to change, and we undertake no obligation to update such statements.


For further information, please contact:
Jill Bertotti
Allen & Caron
+1-949-474-4300
jill@allencaron.com



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES